Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Jesús Loarce-MartosJames B LillekerMattthew James Sinclair ParkerNeil McHughGabriela Arredondo Hector ChinoyPublished in: Rheumatology (Oxford, England) (2021)
Our study confirms that PM can now be considered a rare IIM subgroup. A thorough examination, complete myositis autoantibody panel, and careful interpretation of the biopsy results is recommended to confirm the correct IIM sub-type.